Fundraising Fox

Ossium Health

San Francisco, US · Founded 2016 · Delaware corporation · 105 employees on LinkedIn · 7 known investors

Find your way into Ossium Health

1,970 people in our graph share verified history with the Ossium Health team — schools, employers, funds. One of them is your warm intro.

Chris Bischoffunlockedknows Sebastian Giwa · together at Goldman Sachs (overlapped)
×3knows the team · via Harvard Business School
knows the team · via Indiana University Bloomington
×5knows the team · via McKinsey & Company
knows the team · via Harvard University
knows the team · via Stockholm School of Economics

Ossium Health develops cellular therapies and bioengineered products for clinical use, leveraging adult stem cell technologies and advanced cell processing platforms. The company operates as a clinical-stage biotech firm manufacturing and distributing cellular therapeutics for patients with organ and tissue diseases.

BiotechHealthtechMedical Devices

Founders & leadership

Ossium Health was founded in 2016 by Kevin Caldwell, Dr. Woods, Sebastian Giwa, and Erik Woods.

KCKevin Caldwell
Kevin CaldwellinCEO, Co-Founder & PresidentKevin Caldwell is CEO and co-founder of Ossium Health, a clinical-stage biotech company developing cellular therapies using adult stem cell technologies. He previously worked as an Engagement Manager at McKinsey's San Francisco office focusing on technology clients and as a Senior Investment Associate at Bridgewater Associates conducting quantitative research, and holds degrees from MIT and Harvard Law School.
DW
Dr. WoodsChief Science Officer, Co-Founder, EVP, CLIA Laboratory Director
SGSebastian Giwa
Sebastian GiwainFounder, CEO and Executive Chairman2014–2018Sebastian Giwa holds a PhD in Economics from Stockholm School of Economics and Harvard, and an MBA from Harvard Business School. He has founded multiple biotech companies including Ossium Health, Sylvatica Biotech, Elevian, and Expanse Bio, and previously worked in research and investing at Bridgewater Associates and in consulting at Bain and Goldman Sachs.
EWErik Woods
Erik WoodsinCo Founder, Executive Vice President and Chief Science OfficerHe previously co-founded General BioTechnology LLC, which was acquired by COOK Medical, and held an officer role at Medistem, Inc., which was acquired by Intrexon Corp, bringing expertise in biotech operations, regulatory affairs, and quality systems.

Board

WTWilliam Trenchard
William Trenchardin𝕏Board directorPartner at First Round Capital
TC
Thomas CycyotaBoard director

Investors · 7

FemHealth VenturesShort Hills
Hemisphere Ventures LLCMckinney
Manta Ray VenturesLondon
Vivo CapitalPalo Alto · $10M – $50M
XYZ Venture CapitalSan Francisco · $10K – $5M
First Round CapitalreportedSan Francisco · $1M – $7M
Village GlobalreportedCovina · $100K – $500K

Reported raises · per SEC filings

Form D private placements

$10.4M disclosed across 1 round · 2018

▶$10.4MraisedMay 2018 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William TrenchardDirector
  • Kevin CaldwellExecutive Officer, Director
  • Erik WoodsExecutive Officer, Director
  • Sebastian GiwaDirector
  • Thomas CycyotaDirector
Offering amount
$10.4M
Amount sold
$10.4M
First sale
May 2018
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap
Elysium Health Website16 shared keywordsElysium develops healthcare products focused on aging research and healthy aging rather than disease treatment. The company translates aging research into accessible solutions for individuals seeking to improve their long-term health outcomes.
Globus Medical8 shared keywordsGlobus Medical designs and manufactures spine, trauma, and robotic surgical products for the orthopedic medical device market. The company serves hospitals and surgical centers globally.

Companies competing with Ossium Health for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 9 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2021$248.5K
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2021$224.5K
National Institutes of Health (NIH)National Institutes of HealthPhase II2020$1.5M
National Institutes of Health (NIH)National Institutes of HealthPhase I2020$300K
National Institutes of Health (NIH)National Institutes of HealthPhase I2020$299.9K
National Institutes of Health (NIH)National Institutes of HealthPhase II2019$1.7M
National Institutes of Health (NIH)National Institutes of HealthPhase I2018$225K
National Institutes of Health (NIH)National Institutes of HealthPhase I2017$272.6K
National Institutes of Health (NIH)National Institutes of HealthPhase I2017$239.1K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Ossium Health do?
Ossium Health develops cellular therapies and bioengineered products for clinical use, leveraging adult stem cell technologies and advanced cell processing platforms. The company operates as a clinical-stage biotech firm manufacturing and distributing cellular therapeutics for patients with organ and tissue diseases.
Who founded Ossium Health?
Ossium Health was founded by Kevin Caldwell, Dr. Woods, Sebastian Giwa, Erik Woods in 2016.
Who are Ossium Health's investors?
Ossium Health's investors include FemHealth Ventures, Hemisphere Ventures LLC, Manta Ray Ventures, Vivo Capital, XYZ Venture Capital, First Round Capital, Village Global.
How much funding has Ossium Health raised?
Ossium Health has disclosed $10.4M raised across 1 round.
Where is Ossium Health headquartered?
Ossium Health is headquartered in San Francisco, US.